Future Perspectives in KRAS G12C-Mutated NSCLC

In closing, experts share future perspectives in KRAS G12C-mutated NSCLC, emphasizing novel targeted therapies and emerging trials in the evolving treatment landscape.

Related Keywords

,Exploring Hepatotoxicity ,Treatment Outcomes ,Lung Cancer ,Nsclc ,Non Small Cell Lung Cancer ,Mnsclc ,Metastatic Lung Cancer ,Metastatic Nsclc ,Metastatic Non Small Cell Lung Cancer ,